4.7 Article

Defining optimal dosing of ciprofloxacin in patients with septic shock

Related references

Note: Only part of the references are listed.
Article Infectious Diseases

Maximally effective dosing regimens of meropenem in patients with septic shock

Fredrik Sjovall et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)

Article Medicine, General & Internal

The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)

Mervyn Singer et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)

Article Chemistry, Medicinal

Origins of the Quinolone Class of Antibacterials: An Expanded Discovery Story

Gregory S. Bisacchi

JOURNAL OF MEDICINAL CHEMISTRY (2015)

Review Infectious Diseases

Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions

Jason A. Roberts et al.

LANCET INFECTIOUS DISEASES (2014)

Article Pharmacology & Pharmacy

Two general methods for population pharmacokinetic modeling: non-parametric adaptive grid and non-parametric Bayesian

Tatiana Tatarinova et al.

JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2013)

Article Infectious Diseases

Ciprofloxacin use in critically ill patients: pharmacokinetic and pharmacodynamic approaches

Jean-Marie Conil et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2008)

Article Critical Care Medicine

Ciprofloxacin pharmacokinetics in critically ill patients: A prospective cohort study

Arthur R. H. van Zanten et al.

JOURNAL OF CRITICAL CARE (2008)

Article Microbiology

Impact of sample size on the performance of multiple-model pharmacokinetic simulations

Vincent H. Tam et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)

Article Pharmacology & Pharmacy

Prediction discrepancies for the evaluation of nonlinear mixed-effects models

France Mentre et al.

JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2006)

Review Pharmacology & Pharmacy

The safety profile of the fluoroquinolones

J Bertino et al.

CLINICAL THERAPEUTICS (2000)